Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cann Group ( (AU:CAN) ) just unveiled an announcement.
Cann Group delivered its first-ever free cash flow positive quarter in the three months to 31 December 2025, supported by a FY25 R&D tax credit refund and tighter cost controls, even as quarterly revenue eased to $1.6 million amid seasonal softness. Operating cash inflow was $0.186 million, payments to suppliers and staff were 32% lower than the prior corresponding period, gross margins improved to 55% in December, and export partnering discussions advanced with purchase orders and rising demand for new products and genetics. The company also executed a major balance sheet reset, cutting total debt from about $70.4 million to $14.8 million by settling with NAB and refinancing with an existing private credit lender, alongside a $9 million equity raising that, together with higher margins and cost reductions, is intended to underpin a shift toward sustainable positive operating cash flows and strengthen Cann Group’s financial position.
The most recent analyst rating on (AU:CAN) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Cann Group stock, see the AU:CAN Stock Forecast page.
More about Cann Group
Cann Group Limited is an Australian-listed medicinal cannabis company involved in the cultivation, production and supply of cannabis-derived products, with a focus on both domestic and export markets. The company is advancing branded products such as Lazer Fuel and developing new cannabis genetics to capture growing demand in the medical and related cannabis sectors.
Average Trading Volume: 7,404,470
Technical Sentiment Signal: Sell
Current Market Cap: A$14.3M
For a thorough assessment of CAN stock, go to TipRanks’ Stock Analysis page.